DrugPatentWatch Database Preview
Profile for United States of America Patent: 2010152097
US Patent Family Members and Approved Drugs for United States of America Patent: 2010152097
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Apr 13, 2025 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
➤ Sign Up | Apr 13, 2025 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
➤ Sign Up | Apr 13, 2025 | Astrazeneca Ab | BYDUREON BCISE | exenatide |
➤ Sign Up | Apr 13, 2025 | Astrazeneca Ab | FARXIGA | dapagliflozin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |